{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T09:26:56Z","timestamp":1758274016154,"version":"3.41.0"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>We performed bone scintigraphy in 6 patients with suspected cardiac amyloidosis. To evaluate feasibility of left ventricle function analysis, we additionally performed electrocardiographically gated SPECT acquisition. The cardiac-gated SPECT data confirmed adequate tracer uptake for automatic myocardial contour determination. LVEF estimations ranged between 24% and 54%. Comparison with LVEF estimations from prior echocardiography generally showed only small differences. In one patient, the LVEF measurements from both methods seemed discordant, probably reflecting actual LVEF worsening, which was confirmed at follow-up echocardiography. Therefore, our results may suggest that cardiac-gated SPECT acquisition at bone scintigraphy can provide meaningful estimates of LVEF.<\/jats:p>","DOI":"10.1097\/rlu.0000000000004597","type":"journal-article","created":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T17:07:00Z","timestamp":1676653620000},"page":"448-450","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Feasibility of Left Ventricle Ejection Fraction Calculation Using Electrocardiographically Gated SPECT Acquisition of 99mTc-HDP Bone Scintigraphy in Cardiac Amyloidosis"],"prefix":"10.1097","volume":"48","author":[{"given":"Erik T.","family":"te Beek","sequence":"first","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Lafeber","sequence":"additional","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan W.A.","family":"Postema","sequence":"additional","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Constandse","sequence":"additional","affiliation":[{"name":"Cardiology, Reinier de Graaf Hospital, Delft, the Netherlands."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eelko","family":"Ronner","sequence":"additional","affiliation":[{"name":"Cardiology, Reinier de Graaf Hospital, Delft, the Netherlands."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc R.J.","family":"ten Broek","sequence":"additional","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,2,17]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","year":"2016","journal-title":"Circulation"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1007\/s00259-018-4013-4","article-title":"Diagnostic accuracy of bone scintigraphy in the assessment of cardiac transthyretin-related amyloidosis: a bivariate meta-analysis","volume":"45","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s12350-017-0922-z","article-title":"Accuracy of 99mTc-hydroxymethylene diphosphonate scintigraphy for diagnosis of transthyretin cardiac amyloidosis","volume":"26","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2005.05.073","article-title":"Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy","volume":"46","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1007\/s12350-019-01760-6","article-title":"ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2\u2014evidence base and standardized methods of imaging","volume":"26","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"bib6-20250621","first-page":"2138","article-title":"Automatic quantification of ejection fraction from gated myocardial perfusion SPECT","volume":"36","year":"1995","journal-title":"J Nucl Med"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"e181456","DOI":"10.1001\/jamanetworkopen.2018.1456","article-title":"Variability in ejection fraction measured by echocardiography, gated single-photon emission computed tomography, and cardiac magnetic resonance in patients with coronary artery disease and left ventricular dysfunction","volume":"1","year":"2018","journal-title":"JAMA Netw Open"},{"year":"2022","journal-title":"J Nucl Cardiol","article-title":"First experience of LVEF assessment with cardiac amyloid SPECT scan","key":"bib8-20250621"},{"key":"bib9-20250621","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"key":"bib10-20250621","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jacc.2009.01.005","article-title":"Impact of contrast echocardiography on evaluation of ventricular function and clinical management in a large prospective cohort","volume":"53","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"bib11-20250621","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s12350-020-02396-7","article-title":"Prognostic significance of incidental suspected transthyretin amyloidosis on routine bone scintigraphy","volume":"29","year":"2022","journal-title":"J Nucl Cardiol"},{"key":"bib12-20250621","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","year":"2021","journal-title":"Eur Heart J"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004597","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T19:02:17Z","timestamp":1750532537000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,17]]},"references-count":12,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000004597","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"type":"electronic","value":"1536-0229"},{"type":"print","value":"0363-9762"}],"subject":[],"published":{"date-parts":[[2023,2,17]]}}}